[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-350198-105":3,"detail-sidebar-cat-0-en-105":85,"doc-detail-350198-en":134},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":78,"head_meta":80,"extra_data":82,"updated_unix":84},105,"en","propionate-metabolism-is-dysregulated-in-non-small-cell-lung-cancer-patients-and-egfr-mutant-drug-tolerant-persister-cells-research-findings","Propionate metabolism is dysregulated in non-small cell lung cancer patients and EGFR-mutant drug-tolerant persister cells - research findings","","Propionate metabolism dysregulation is presented as a non-genetic mechanism contributing to drug resistance in non-small cell lung cancer (NSCLC). The work reports elevated methylmalonic acid (MMA) levels in lung tumors and in the serum of patients with metastatic NSCLC, alongside downregulation of the cobalamin associated B gene (MMAB) in tumors and EGFR-mutant drug-tolerant persister cells. Restoring MMAB expression is shown to enhance targeted therapy and suppress TGFβ signaling, with MMA accumulation linked to epithelial-to-mesenchymal transition activation. Propionate metabolism is highlighted as a potential therapeutic target.",{"@graph":14,"@context":77},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/propionate-metabolism-is-dysregulated-in-non-small-cell-lung-cancer-patients-and-egfr-mutant-drug-tolerant-persister-cells-research-findings/350198/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/propionate-metabolism-is-dysregulated-in-non-small-cell-lung-cancer-patients-and-egfr-mutant-drug-tolerant-persister-cells-research-findings/350198.png","ImageObject",300,407,{"name":42,"@type":43},"Fahsai","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-12","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69,73],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does the study address in non-small cell lung cancer?","Question",{"text":63,"@type":64},"Drug resistance in EGFR-mutant NSCLC cannot be fully explained by genetic sequencing, indicating additional non-genetic survival mechanisms in cancer cells.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How is propionate metabolism dysregulation detected in patients and models?",{"text":68,"@type":64},"Methylmalonic acid (MMA) is elevated in lung tumors and in serum from patients with metastatic NSCLC, and MMAB expression is downregulated in NSCLC and drug-tolerant persister cells.",{"name":70,"@type":61,"acceptedAnswer":71},"What is the proposed role of MMA and MMAB in drug-tolerant persister cells?",{"text":72,"@type":64},"MMAB downregulation leads to MMA accumulation, which activates epithelial-to-mesenchymal transition (EMT) and supports drug-tolerant persister survival.",{"name":74,"@type":61,"acceptedAnswer":75},"Why is restoring MMAB expression considered therapeutically relevant?",{"text":76,"@type":64},"Restoring MMAB expression in NSCLC enhances targeted therapy and suppresses TGFβ signaling, linking propionate metabolism to actionable drug resistance pathways.","https://schema.org",{"og:url":32,"og:type":79,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":81,"canonical":32},"index,follow",{"doc_id":83,"site_id":7},350198,1790216681,{"code":4,"msg":86,"data":87},"success",[88,92,96,100,105,110,115,119,124,127,130],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":97,"show_sort_weight":98,"slug":99},"Exam",70,"exam",{"id":101,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},5,"Comic",60,"comic",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},6,"Technology",50,"technology",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":112,"show_sort_weight":113,"slug":114},7,"Healthcare",40,"healthcare",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":117,"slug":118},8,30,"research-report",{"id":120,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":122,"slug":123},9,"Religion & Spirituality",20,"religion-spirituality",{"id":122,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":122,"slug":126},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":55,"slug":129},"Lifestyle","lifestyle",{"id":131,"doc_module":4,"doc_module_name":25,"category_name":132,"show_sort_weight":101,"slug":133},19,"General","general",{"code":4,"msg":86,"data":135},{"doc_id":83,"user_id":136,"nickname":42,"user_avatar":137,"doc_module":4,"category_id":116,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":143,"language":144,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":145,"faqs":146,"seo_title":147,"seo_description":12,"update_tm":148,"read_time":149,"preview_page_count":33,"preview_urls":150},549768702563,"https://ap-avatar.wpscdn.com/avatar/8000c4aa63b76e948b?x-image-process=image/resize,m_fixed,w_180,h_180&k=1786536092046926083","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nPropionate metabolism is dysregulated in non-small cell lung cancer patients and EGFR-mutant drug-tolerant persister cells  \nBobak Parang1,2􀀍, LironYoffe3, Rabia Khan4, Zhongchi Li4, Michal J. Nagiec4, Eric E. Gardner5, Yiwey Shieh4, Rachel S. Heise4, Ashish Saxena4, Nasser Altorki6 & John Blenis4,7􀀍  \nRecent studies show that genetic sequencing can not fully explain drug resistance in non-small cell lung cancer (NSCLC), suggesting undiscovered non-genetic mechanisms that can enable cancer cell survival. Propionate metabolism is the pathway by which odd-chain fatty acids, branched chain amino acids, and cholesterol are metabolized. We have previously shown that methylmalonic acid (MMA), a byproduct of propionate metabolism that accumulates when the pathway is disrupted, can activate epithelial-to-mesenchymal transition (EMT) in cell lines. But the clinical significance of propionate metabolism in cancer patients is not known. Here we show, for the first time, that propionate metabolism is dysregulated in patients with non-small cell lung cancer. MMA is elevated in lung tumorsand in the serum of patients with metastatic NSCLC. Metabolism of cobalamin associated B (MMAB), a key regulatory gene of propionate metabolism, is downregulated in NSCLC and drug-tolerant persister cells, leading to MMA accumulation and EMT activation. We show that restoring expression of MMABin NSCLC enhances targeted therapy and suppressesTGFβ signaling. These findings reveal propionate metabolism dysregulation as a non-genetic mechanism of drug resistance and highlight propionate metabolism as a potential therapeutic target.  \nKeywords Lung cancer, Drug-tolerant persister, EGFR-mutant, Propionate metabolism  \nNon-small cell lung cancer is the leading cause of cancer-related deaths worldwide1. Epidermal growth factor receptor (EGFR)-mutant NSCLC is a subset of lung cancer driven by oncogenic mutations that render EGFR constitutively active. EGFR-mutant NSCLC kills approximately 250,000 patients worldwide annually2,3. The development of small molecule inhibitors, like osimertinib, that inhibit the EGFR kinase has dramatically improved outcomes for patients with metastatic disease4, but invariably, residual disease persists and eventually gives rise to proliferative, resistant disease. These residual cancer cells are known as “drug-tolerant persister”cells (DTPs) and are characterized by slow-cycling and activation of epithelial-to-mesenchymal transition (EMT) and injury-response transcriptional signatures5. Enrichment ofTGFβ, YAP, and β-catenin signaling have been implicated in sustaining DTP survival6–8. Although our understanding of DTP transcriptional states has advanced significantly, our understanding of DTPs metabolic regulation remains incomplete. Indeed, a more complete understanding of DTPs metabolic states may provide new insights into vulnerabilities that could be targeted.  \nPropionate metabolism is the metabolic pathway by which odd-chain fatty acids, branched chain amino acids, and cholesterol proceed through a series of enzymatic reactions to produce succinate9. Succinate then enters the TCA cycle to produce ATP. Appropriate regulation of propionate metabolism involves a complex set of proteins including propionyl-CoA carboxylase subunit alpha (PCCA), propionyl-CoA carboxylase subunit beta  \n1Department of Medicine, Division of Medical Oncology, The Ohio State University, Columbus, OH 43210, USA.  \n2The Ohio State University, The James Cancer Center Biomedical Research Tower, 460 W 12th Avenue, Columbus, OH 43210, USA. 3Radiation Oncology, Weill Cornell Medicine, New York, USA. 4Meyer Cancer Center, Weill Cornell Medicine, New York, NY 10021, USA. 5University of Texas M. D. Anderson Cancer Center, 77030 Houston, TX, USA.  \n6Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY 10021, USA. 7Sandra and Edward Meyer Cancer Center, Belfer Research Building 4","cbCaigeG8jmYRLJt","https://ap.wps.com/l/cbCaigeG8jmYRLJt","pdf",3006985,11,"English","# Background\n## Drug resistance and DTP biology in EGFR-mutant NSCLC\n## Propionate metabolism and MMA\n# Findings and mechanism\n## Dysregulation of propionate metabolism in patients and cells\n## MMAB downregulation, MMA accumulation, and EMT activation\n## Therapeutic implications of restoring MMAB expression","[{\"question\":\"What problem does the study address in non-small cell lung cancer?\",\"answer\":\"Drug resistance in EGFR-mutant NSCLC cannot be fully explained by genetic sequencing, indicating additional non-genetic survival mechanisms in cancer cells.\"},{\"question\":\"How is propionate metabolism dysregulation detected in patients and models?\",\"answer\":\"Methylmalonic acid (MMA) is elevated in lung tumors and in serum from patients with metastatic NSCLC, and MMAB expression is downregulated in NSCLC and drug-tolerant persister cells.\"},{\"question\":\"What is the proposed role of MMA and MMAB in drug-tolerant persister cells?\",\"answer\":\"MMAB downregulation leads to MMA accumulation, which activates epithelial-to-mesenchymal transition (EMT) and supports drug-tolerant persister survival.\"},{\"question\":\"Why is restoring MMAB expression considered therapeutically relevant?\",\"answer\":\"Restoring MMAB expression in NSCLC enhances targeted therapy and suppresses TGFβ signaling, linking propionate metabolism to actionable drug resistance pathways.\"}]","Propionate metabolism is dysregulated in non-small cell lung cancer patients and EGFR-mutant drug-tolerant persister cells - research findings | PDF",1790087689,28,[151,155,159,163],{"page_no":22,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0e8b11e62308a035a3b35b1568c40a56.webp",983,1291,{"page_no":26,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3ff1114f2b574f8ed3d6025bb03f7791.webp",982,1290,{"page_no":30,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b7d6af43f4e7385841b4db3bb8dd90f7.webp",981,1289,{"page_no":33,"url":164,"width":165,"height":166},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/79b95a7979a7f80bb44d39c0575e08fe.webp",980,1287]